valine has been researched along with Chronic Disease in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.06) | 18.7374 |
1990's | 4 (5.06) | 18.2507 |
2000's | 42 (53.16) | 29.6817 |
2010's | 27 (34.18) | 24.3611 |
2020's | 2 (2.53) | 2.80 |
Authors | Studies |
---|---|
Ayada, I; Bakkali, A; Benninga, MA; Claesen, J; de Boer, NKH; de Meij, TGJ; Jagt, JZ; Jansen, EEW; Struys, EA; van Limbergen, JE | 1 |
Arias-Fernández, L; Banegas, JR; Caballero, FF; Cárdenas-Valladolid, J; Lana, A; Lopez-Garcia, E; Rodríguez-Artalejo, F; Salinero-Fort, MÁ; Struijk, EA; Yévenes-Briones, H | 1 |
Falhas, C; Henrique, M; Kieselova, K; Santiago, F | 1 |
Araki, N; Eguchi, Y; Iwane, S; Kawakubo, M; Koga, A; Nakashita, S; Oeda, S; Okada, M; Otsuka, T | 1 |
Ghosh, R; Lahiri, G; Paul, R; Roy, D; Ruia, AV; Sarkar, R; Sau, TJ | 1 |
Hoesly, FJ; Sluzevich, JC | 1 |
Chang, JC; Chang, WP; Chen, IM; Cheng, JK; Chiu, HF; Lin, CH; Lin, CI; Lin, PH | 1 |
Bygum, A; Clemmensen, O; Fisker, N; Pahlow Mose, A | 1 |
Bramlage, P; Ferrero, C; Gomez, T; Minguet, J; Sutton, G | 1 |
Fang, H; Liu, XY; Soares, JC; Xu, G; Zhang, XY; Zhao, J; Zhen, YF | 1 |
Arslan, H; Bilezikçi, B; Haberal, M; Moray, G; Ozçay, F; Sevmiş, S | 1 |
Anand, IS; Bishu, K; Cohn, JN; Ishani, A; Kuskowski, MA; Rector, TS | 1 |
Iannazzo, S; Pradelli, L; Zaniolo, O | 1 |
Haas, DW; Johnson, B; Luther, JM; Nicotera, J; Smith, JP; Weller, S | 1 |
Ekhlas, A; Esnault, VL; Moranne, O; Nguyen, JM | 1 |
Chung, CC; MacLeod, BA; Puil, E; Ries, CR; Schwarz, SK; Wang, JT | 1 |
Suzuki, H; Takenaka, T | 1 |
Battaglia, G; Cambareri, F; Carminati, S; Cravedi, P; David, S; Ene-Iordache, B; Gaspari, F; Granata, A; Ledda, F; Loriga, G; Motterlini, N; Perna, A; Remuzzi, G; Rota, S; Rubis, N; Ruggenenti, P; Satta, A; Stucchi, N; Tonelli, M | 1 |
Kamide, K; Maekawa, Y; Ohishi, M; Onishi, M; Rakugi, H; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
Allchorne, A; Barrett, LB; Belfer, I; Cobos, EJ; Coppola, G; Costigan, M; Dai, F; Diatchenko, L; Gershon, E; Geschwind, DH; Goldman, D; Griffin, RS; Karppinen, J; Kelempisioti, A; Kiselycznyk, C; Livneh, J; Lu, Y; Maixner, W; Männikkö, M; Max, MB; Nikolajsen, L; Poddar, M; Seltzer, Z; Shen, PH; Smith, S; Woolf, CJ; Wu, T; Zaykin, D | 1 |
Hosoya, T; Ishii, T; Kawamura, T; Tsuboi, N | 1 |
Covault, J; Davis, MC; Finan, PH; Lemery-Chalfant, K; Tennen, H; Zautra, AJ | 1 |
Chaiyakunapruk, N; Cheewasithirungrueng, N; Dilokthornsakul, P; Jeanpeerapong, N; Nimpitakpong, P; Srisupha-olarn, W; Thanarungroj, A | 1 |
Chae, DW; Do, JY; Huh, W; Jang, HR; Kim, DJ; Kim, SG; Kim, YG; Lee, JE; Lee, YJ; Oh, HY | 1 |
Derbentseva, EA; Dralova, OV; Maksimov, MA; Ostroumova, OD; Starodubtsev, AK | 1 |
Aparasu, RR; Ashton, CM; Chen, H; Desai, RJ; Deswal, A; Johnson, ML; Mehta, HB; Morgan, RO | 1 |
Hemmelder, MH; Janssen, WM; Lambers Heerspink, HJ; Laverman, GD; Navis, G; Slagman, MC; Waanders, F; Woittiez, AJ | 1 |
Chen, C; Le, X; Sun, S; Tang, Y; Wang, M; Yin, Y | 1 |
Iványi, JL; Marton, E; Plander, M | 1 |
Banks, S; Dinges, DF; Goel, N; Lin, L; Mignot, E | 1 |
Kumagai, H; Matsubara, H; Oda, T; Ohshima, N; Senda, M; Tadano, H; Takechi, H; Uchida, T; Watanabe, A; Yamamoto, K | 1 |
Auleley, GR; Boutron, I; Konrat, C; Ravaud, P; Ricordeau, P; Trinquart, L | 1 |
Patel, R | 1 |
Wood, M | 1 |
Bilder, RM; Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Goldman, RS; Hoptman, MJ; Kennedy, JL; Kunz, M; Lieberman, JA; Lindenmayer, JP; Malhotra, AK; McEvoy, JP; Ni, X; Sheitman, B; Volavka, J | 1 |
Anand, I; Bevilacqua, M; Cardano, P; Chiang, YT; Cohn, JN; Dunselman, PH; Holwerda, NJ; Judd, D; Latini, R; Maggioni, AP; Masson, S; Salio, M; Tognoni, G | 1 |
Hollenberg, NK | 1 |
Aros, C; Bertocchi, F; Campbell, R; Fagiani, L; Perna, A; Perticucci, E; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F; Viscarra, C | 1 |
Kohno, M | 1 |
Dickinson, RP; Fray, MJ; Huggins, JP; Occleston, NL | 1 |
Anand, IS; Chiang, YT; Cohn, JN; Glazer, R; Latini, R; Masson, S | 1 |
Boehler, A; Laube, I; Renner, EL; Speich, R | 1 |
McMurray, JJ; Swedberg, K | 1 |
Hong, CJ; Lai, IC; Liao, DL; Liou, YJ; Tsai, SJ | 1 |
Suzuki, H | 1 |
Anavekar, NS; Califf, RM; Dickstein, K; Kober, L; Leimberger, JD; Maggioni, A; McMurray, JJ; Nordlander, R; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, EJ; White, HD; Zelenkofske, S | 1 |
Aknay, N; Anand, IS; Chiang, YT; Cohn, JN; Florea, VG; Glazer, RD; Hester, A; Kuskowski, MA; Latini, R; Maggioni, AP; Opasich, C; Rector, TS | 1 |
Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV | 1 |
Barrios Alonso, V; Calderón Montero, A; Escobar Cervantes, C | 1 |
Bodaghi, B; Chiquet, C; Mougin, C; Najioullah, F | 1 |
Hagen, K; Pettersen, E; Skorpen, F; Stovner, LJ; Zwart, JA | 1 |
Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Orlova, IaA; Skvortsov, AA; Sychev, AV | 1 |
Anand, I; Carretta, E; Cohn, J; Glazer, R; Ingrillì, F; Krum, H; Latini, R; Maggioni, AP; Masson, S; Pettinati, G; Tognoni, G | 1 |
Cohn, JN | 1 |
Aslanidis, C; Buechler, C; Herfarth, H; Schäffler, A; Wobser, H; Zeitoun, M | 1 |
Chen, Q; Cross, NC; Jones, AV; Lu, P; Silver, RT; Wang, YL | 1 |
Akazawa, H; Komuro, I; Kudo, Y | 1 |
Cao, LY; Kosten, TA; Kosten, TR; Li, J; Lu, L; Tan, YL; Wang, ZR; Wu, GY; Zhang, XY; Zhou, DF | 1 |
Cao, LY; Haile, CN; Kosten, TA; Kosten, TR; Li, J; Lu, L; Tan, YL; Wu, GY; Zhang, XY; Zhou, DF | 1 |
Deswal, A; Mann, DL; Ramasubbu, K | 1 |
Chen, WD; Huang, YY; Li, LH; Wang, YW; Xu, HH; Yang, LC; Yang, YL; Zhang, DY; Zhu, XJ | 1 |
Hill, EL; Kern, ER; Koelle, DM; Lawrence, W; Posavad, CM; Safrin, S; Swetter, SM | 1 |
Cohn, JN; Glazer, RD; Hester, A; Spormann, D; Tognoni, G | 1 |
Pfützer, RH; Whitcomb, DC | 1 |
Andriulli, A; Chen, JM; Deprez, PH; Ferec, C; Raguenes, O; Verellen-Dumoulin, C | 1 |
Bennett, AD; Everhart, AW; Hulsebosch, CE | 1 |
Emmert, DH | 1 |
Landow, K | 1 |
Basset, A; Blanc, J; Elghozi, JL | 1 |
Kozlovskaia, NL; Medvedeva, TIu; Miroshnichenko, NG; Okonova, EB; Plieva, OK; Rudenko, TE; Shonichev, DG; Shvetsov, MIu; Stavrovskaia, EV | 1 |
Komajda, M | 1 |
Cohn, JN; Tognoni, G | 1 |
Carretta, R; Fogari, R; Salvetti, A; Veglio, F; Zoppi, A | 1 |
Houghton, AR | 1 |
Jones, MR; Kopple, JD | 1 |
Gundalakh, AI; Mel'k, MV; Shcheglova, SA; Volkova, ZA | 1 |
Ivano, E; Kr"steva, A; Lozanova, L; Nedkov-Bratanova, N; Nikolov, N | 1 |
Doszpod, J; Fekete, M; Gáti, I; Járai, I; Mestyán, J; Preisz, J; Soltész, G | 1 |
14 review(s) available for valine and Chronic Disease
Article | Year |
---|---|
LCZ696 : a new paradigm for the treatment of heart failure?
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chronic Disease; Clinical Trials, Phase II as Topic; Drug Combinations; Heart Failure; Humans; Neprilysin; Prospective Studies; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2015 |
[Recent clinical evidences of RAS inhibitors on chronic kidney diseases].
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Evidence-Based Medicine; Fumarates; Kidney Diseases; Losartan; Tetrazoles; Valine; Valsartan | 2010 |
[Recent advance in kidney and hypertension research].
Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Agonists; Catheter Ablation; Cerebrovascular Circulation; Chronic Disease; Diabetic Nephropathies; Drug Therapy, Combination; Evidence-Based Medicine; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2012 |
Progress in meeting today's demands in genital herpes: an overview of current management.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antiviral Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Famciclovir; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Immunocompetence; Patient Education as Topic; Prodrugs; Secondary Prevention; Treatment Outcome; Valacyclovir; Valine | 2002 |
Understanding pain in herpes zoster: an essential for optimizing treatment.
Topics: 2-Aminopurine; Acyclovir; Analgesics; Antiviral Agents; Chronic Disease; Clinical Trials as Topic; Famciclovir; Herpes Zoster; Herpesvirus 3, Human; Humans; Meta-Analysis as Topic; Pain; Pain Measurement; Proportional Hazards Models; Treatment Outcome; Valacyclovir; Valine | 2002 |
[Pharmacological treatment of heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Infusions, Intravenous; Pyridazines; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2003 |
Angiotensin type 1 receptor blockers in chronic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Clinical Trials as Topic; Diabetic Nephropathies; Humans; Kidney Diseases; Losartan; Tetrazoles; Valine; Valsartan | 2004 |
[ARB II in chronic heart failure. Coincidences and divergences. Class effect?].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Heart Failure; Humans; Losartan; Systole; Tetrazoles; Valine; Valsartan | 2005 |
Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Heart Failure; Humans; Long-Term Care; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2000 |
[Pharmocological therapeutics for chronic heart failure--how to use ARB (angiotensin receptor blocker].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Losartan; Myocardial Infarction; Severity of Illness Index; Survival Rate; Tetrazoles; Valine; Valsartan | 2007 |
Anti-angiotensin therapy: new perspectives.
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Fumarates; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Renin; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2007 |
Treatment of common cutaneous herpes simplex virus infections.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chronic Disease; Diagnosis, Differential; Drug Costs; Famciclovir; Herpes Genitalis; Herpes Labialis; Herpes Simplex; Humans; Patient Education as Topic; Teaching Materials; Valacyclovir; Valine | 2000 |
Acute and chronic herpes zoster. An ancient scourge yields to timely therapy.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Aged; Antiviral Agents; Chronic Disease; Famciclovir; Herpes Zoster; Humans; Neuralgia; Risk Factors; Valacyclovir; Valine | 2000 |
Angiotensin II receptor antagonists in chronic heart failure: where do they fit?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2002 |
17 trial(s) available for valine and Chronic Disease
Article | Year |
---|---|
Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria; Ramipril; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Chi-Square Distribution; Chronic Disease; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Italy; Kidney Diseases; Lipids; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2010 |
Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Hawaii; Humans; Hypertension; Imidazoles; Imidazolidines; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2010 |
[Antihypertensive and nephroprotective effectiveness of AT1-angiotensin II receptor blocker valsartan in average therapeutic and maximal daily dose in patients with arterial hypertension and chronic kidney disease].
Topics: Administration, Oral; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Receptor, Angiotensin, Type 1; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan; Vascular Resistance | 2011 |
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Combined Modality Therapy; Cross-Over Studies; Diet, Sodium-Restricted; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Kidney Diseases; Lisinopril; Male; Middle Aged; Patient Compliance; Proteinuria; Sodium Chloride, Dietary; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Survival Rate; Tetrazoles; Time; Valine; Valsartan | 2002 |
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Chronic Disease; Cross-Over Studies; Dextrans; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan | 2003 |
Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Cardiac Output, Low; Chronic Disease; Double-Blind Method; Follow-Up Studies; Humans; Tetrazoles; Valine; Valsartan | 2003 |
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Chronic Disease; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survival Rate; Tetrazoles; Valine; Valsartan | 2004 |
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.
Topics: Aged; Anemia; Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Female; Heart Failure; Hemoglobins; Humans; Logistic Models; Male; Middle Aged; Morbidity; Multivariate Analysis; Prevalence; Prognosis; Survival Analysis; Tetrazoles; Valine; Valsartan | 2005 |
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Renin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2005 |
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling | 2006 |
BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Topics: Analysis of Variance; Antipsychotic Agents; Body Mass Index; Brain-Derived Neurotrophic Factor; Chronic Disease; Female; Genotype; Humans; Inpatients; Male; Methionine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Schizophrenia; Sex Factors; Valine; Weight Gain | 2008 |
[Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
Topics: Adult; Antihypertensive Agents; Chronic Disease; Female; Follow-Up Studies; Glomerulonephritis; Humans; Hypertension; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Proteinuria; Tetrazoles; Time Factors; Valine; Valsartan | 2001 |
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Probability; Quality of Life; Stroke Volume; Survival Analysis; Tetrazoles; Valine; Valsartan | 2001 |
Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Chronic Disease; Drug Interactions; Female; Humans; Hypertension; Indomethacin; Lisinopril; Male; Middle Aged; Osteoarthritis; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2002 |
48 other study(ies) available for valine and Chronic Disease
Article | Year |
---|---|
Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
Topics: Amino Acids; Case-Control Studies; Child; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Feces; Histidine; Humans; Inflammatory Bowel Diseases; Tryptophan; Valine | 2022 |
Prospective Association Between Plasma Amino Acids and Multimorbidity in Older Adults.
Topics: Aged; Amino Acids; Chronic Disease; Female; Glutamine; Humans; Isoleucine; Male; Multimorbidity; Valine | 2023 |
Chronic penile ulcer as the first manifestation of HIV infection.
Topics: Acyclovir; Anti-HIV Agents; Antiviral Agents; Chronic Disease; HIV Infections; HIV-1; Humans; Male; Penile Diseases; Skin Ulcer; Valacyclovir; Valine; Young Adult | 2017 |
Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of Life.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Chronic Disease; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pyrrolidines; Quality of Life; Sulfonamides; Treatment Outcome; Valine | 2018 |
A Patient of Chronic Hepatitis C Complicated by Thalassemia Major and Chronic Osteomyelitis: A Therapeutic Challenge for a Clinician.
Topics: Adolescent; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Carbamates; Chronic Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; Osteomyelitis; Pyrrolidines; Sofosbuvir; Valine | 2018 |
Chronic cutaneous varicella zoster virus infection complicating dermatomyositis.
Topics: Acyclovir; Aged; Antiviral Agents; Chronic Disease; Dermatomyositis; Female; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Skin Diseases, Viral; Valacyclovir; Valine | 2014 |
A mechanistic study on urine retention in d-amphetamine addicts.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Amidines; Amphetamine-Related Disorders; Animals; Benzophenanthridines; Central Nervous System Stimulants; Chronic Disease; Colforsin; Dextroamphetamine; Excitatory Amino Acid Agonists; Female; Glutamic Acid; Isoquinolines; N-Methylaspartate; Oxidants; Protein Kinase Inhibitors; Rats, Wistar; Reflex; Spinal Cord; Sulfonamides; Urinary Retention; Urination; Valine | 2014 |
Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.
Topics: Acyclovir; Antiviral Agents; Child; Chronic Disease; Epstein-Barr Virus Infections; Humans; Hydroa Vacciniforme; Male; Valacyclovir; Valine | 2014 |
Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Brain-Derived Neurotrophic Factor; Chronic Disease; Female; Genetic Association Studies; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Valine; Weight Gain; Young Adult | 2016 |
The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Body Weight; Child, Preschool; Chronic Disease; Epstein-Barr Virus Infections; Humans; Infant; Liver Function Tests; Liver Transplantation; Postoperative Complications; Recurrence; Retrospective Studies; Valacyclovir; Valine; Viral Load; Virus Activation | 2009 |
The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
Topics: Age Factors; Aged; Antihypertensive Agents; Chronic Disease; Computer Simulation; Cost-Benefit Analysis; Drug Costs; Female; Heart Failure; Hospital Costs; Humans; Italy; Male; Markov Chains; Middle Aged; Models, Statistical; Quality of Life; Quality-Adjusted Life Years; Sex Factors; Tetrazoles; Valine; Valsartan | 2009 |
Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Chronic Disease; Female; Guanine; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Medical Futility; Middle Aged; Prodrugs; Valacyclovir; Valine; Young Adult | 2010 |
Analgesic properties of the novel amino acid, isovaline.
Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; beta-Alanine; Chronic Disease; Cisterna Magna; Female; Formaldehyde; Glutamic Acid; Glycine; Hypnotics and Sedatives; Injections; Injections, Intravenous; Injections, Spinal; Mice; Models, Molecular; Pain; Pain Measurement; Postural Balance; Receptors, Glutamate; Strychnine; Valine | 2010 |
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.
Topics: Animals; Chronic Disease; Cohort Studies; Comprehension; Computational Biology; Cross-Cultural Comparison; Disease Models, Animal; Female; Ganglia, Spinal; Gene Expression Profiling; Gene Expression Regulation; Genome-Wide Association Study; Genotype; Humans; Kv1.1 Potassium Channel; Linkage Disequilibrium; Male; Neurofilament Proteins; Neuropeptides; Oligonucleotide Array Sequence Analysis; Pain; Polymorphism, Genetic; Rats; Valine | 2010 |
[CCB uptitration is superior to ARB uptitration in CKD patients who do not reach target blood pressure with ARB/CCB combined therapy].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Drug Therapy, Combination; Glomerular Filtration Rate; Hypertension; Kidney Diseases; Nifedipine; Tetrazoles; Time Factors; Valine; Valsartan | 2010 |
COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia.
Topics: Adaptation, Psychological; Catechol O-Methyltransferase; Chronic Disease; Female; Fibromyalgia; Genetic Variation; Humans; Methionine; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Valine | 2011 |
Estimation of financial burden due to oversupply of medications for chronic diseases.
Topics: Aged; Atorvastatin; Chronic Disease; Clopidogrel; Drug Costs; Female; Heptanoic Acids; Hospitals, University; Humans; Male; Middle Aged; Pharmaceutical Preparations; Phenylcarbamates; Pyrroles; Retrospective Studies; Rivastigmine; Rosiglitazone; Tetrazoles; Thailand; Thiazolidinediones; Ticlopidine; Valine; Valsartan | 2012 |
Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Chronic Disease; Female; Genotype; Humans; Kidney; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prospective Studies; Protective Agents; Proteinuria; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2011 |
Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Confounding Factors, Epidemiologic; Electronic Health Records; Female; Heart Failure; Hospitalization; Humans; Irbesartan; Losartan; Male; Models, Structural; Proportional Hazards Models; Retrospective Studies; Risk; Tetrazoles; Treatment Outcome; United States; Valine; Valsartan | 2012 |
Cardiovascular protection with danshensu in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Cardiotonic Agents; Cardiovascular System; Chronic Disease; Drug Administration Schedule; Drug Evaluation, Preclinical; Heart; Heart Function Tests; Hypertension; Lactates; Large-Conductance Calcium-Activated Potassium Channels; Male; Mesenteric Arteries; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type II; Patch-Clamp Techniques; Phytotherapy; Plant Preparations; Plant Roots; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Salvia miltiorrhiza; Tetrazoles; Valine; Valsartan | 2011 |
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Topics: Adult; Aged; Bone Marrow Neoplasms; Chronic Disease; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenylalanine; Polycythemia Vera; Polymerase Chain Reaction; Predictive Value of Tests; Primary Myelofibrosis; Retrospective Studies; Signal Transduction; Thrombocythemia, Essential; Thrombosis; Valine | 2011 |
Catechol-O-methyltransferase Val158Met polymorphism associates with individual differences in sleep physiologic responses to chronic sleep loss.
Topics: Adult; Catechol O-Methyltransferase; Chronic Disease; Electroencephalography; Female; Humans; Male; Methionine; Polymorphism, Genetic; Polysomnography; Sleep Deprivation; Sleep, REM; Valine | 2011 |
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Chronic Disease; Etidronic Acid; Fluorobenzenes; France; Humans; Middle Aged; Pioglitazone; Prescription Drugs; Pyrimidines; Randomized Controlled Trials as Topic; Risedronic Acid; Rosuvastatin Calcium; Sulfonamides; Tetrazoles; Thiazolidinediones; Valine; Valsartan | 2012 |
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
Topics: Adult; Amino Acid Substitution; Attention; Catechol O-Methyltransferase; Chronic Disease; Cognition; Dopamine; Female; Genotype; Humans; Male; Methionine; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Valine | 2002 |
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Evaluation Studies as Topic; Heart Failure; Humans; Incidence; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Stroke Volume; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2002 |
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.
Topics: Administration, Cutaneous; Animals; Caproates; Cell Movement; Cells, Cultured; Chronic Disease; Fibronectins; Gelatin; Humans; Keratinocytes; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Polycyclic Compounds; Protease Inhibitors; Rabbits; Skin; Skin Diseases; Stereoisomerism; Structure-Activity Relationship; Ulcer; Valine | 2003 |
Valaciclovir for chronic hepatitis B virus infection after lung transplantation.
Topics: Acyclovir; Bronchiectasis; Carrier State; Chronic Disease; Female; Follow-Up Studies; Graft Survival; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lung Transplantation; Middle Aged; Postoperative Complications; Preoperative Care; Risk Assessment; Serologic Tests; Treatment Outcome; Valacyclovir; Valine | 2004 |
Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2004 |
Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Aged; Catechol O-Methyltransferase; Chronic Disease; Cognition Disorders; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Psychiatric Status Rating Scales; Regression Analysis; Schizophrenia; Severity of Illness Index; Valine | 2004 |
Acute retinal necrosis diagnosed in a child with chronic panuveitis.
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Aqueous Humor; Child, Preschool; Chronic Disease; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Eye Infections, Viral; Herpes Simplex; Herpesvirus 2, Human; Humans; In Situ Hybridization; Male; Panuveitis; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Valacyclovir; Valine | 2006 |
No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study.
Topics: Adult; Aged; Alleles; Catechol O-Methyltransferase; Chronic Disease; Female; Gene Frequency; Genotype; Humans; Male; Methionine; Middle Aged; Musculoskeletal Diseases; Polymorphism, Genetic; Valine | 2006 |
Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT.
Topics: Aged; Antihypertensive Agents; C-Reactive Protein; Cholesterol; Chronic Disease; Creatinine; Databases, Factual; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morbidity; Prognosis; Retrospective Studies; Tetrazoles; Valine; Valsartan | 2007 |
Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases.
Topics: Amino Acid Substitution; Aspartic Acid; Chronic Disease; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Female; Gene Frequency; GPI-Linked Proteins; Humans; Inflammatory Bowel Diseases; Lectins; Male; Mutation, Missense; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Reference Values; Valine; White People | 2007 |
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.
Topics: Chronic Disease; DNA Mutational Analysis; Exons; Genetic Testing; Genome, Human; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Phenylalanine; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Valine | 2007 |
Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia.
Topics: Adult; Alleles; Asian People; Brain-Derived Neurotrophic Factor; Chromosomes, Human, Pair 11; Chronic Disease; Comorbidity; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; RNA, Messenger; Schizophrenia; Smoking; Tobacco Use Disorder; Valine | 2007 |
[Effects of benazepril and valsartan alone or in combination on proteinuria in chronic glomerular disease].
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chronic Disease; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Male; Middle Aged; Proteinuria; Tetrazoles; Valine; Valsartan; Young Adult | 2007 |
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.
Topics: Acyclovir; Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Female; Foscarnet; Humans; Immunocompetence; Simplexvirus; Thymidine Kinase; Ulcer; Valacyclovir; Valine; Vulvar Diseases | 1998 |
Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic; Reference Values; Research Design; Severity of Illness Index; Survival Rate; Tetrazoles; Treatment Outcome; Valine; Valsartan | 1999 |
Trypsinogen mutations in chronic pancreatitis.
Topics: Alanine; Amino Acid Substitution; Chronic Disease; Humans; Mutation; Pancreatitis; Trypsinogen; Valine | 1999 |
The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis.
Topics: Alanine; Amino Acid Sequence; Amino Acid Substitution; Biological Transport; Chronic Disease; Genetic Testing; Humans; Molecular Sequence Data; Mutation; Pancreatitis; Protein Sorting Signals; Sequence Homology, Amino Acid; Trypsinogen; Valine | 1999 |
Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury.
Topics: Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hyperalgesia; Injections, Spinal; Male; Motor Activity; Pain; Physical Stimulation; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Cord Injuries; Valine | 2000 |
[Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Disease Models, Animal; Fever; Fourier Analysis; Heart Rate; Hypertension; Hyperthyroidism; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Signal Processing, Computer-Assisted; Tachycardia; Tetrazoles; Thyroid Hormones; Thyrotoxicosis; Thyroxine; Valine; Valsartan; Weight Loss | 2000 |
[AT1-blocker in heart failure. Patients are readmitted more infrequently to the clinic].
Topics: Angiotensin Receptor Antagonists; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Patient Readmission; Randomized Controlled Trials as Topic; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2000 |
Are angiotensin II receptor blockers indicated in chronic heart failure?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2002 |
Valine metabolism in normal and chronically uremic man.
Topics: Adult; Aged; Carbon Dioxide; Chronic Disease; Decarboxylation; Dietary Proteins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Oxidation-Reduction; Uremia; Valine | 1978 |
[Some indices of nitrogen metabolism in patients with viral hepatitis].
Topics: Adolescent; Adult; Alanine; Ammonia; Asparagine; Chronic Disease; Cysteine; Cystinuria; Glutamates; Glycine; Hepatitis A; Humans; Isoleucine; Leucine; Methionine; Middle Aged; Nitrogen; Phenylalanine; Serine; Threonine; Urea; Valine | 1975 |
[Dipeptidase activity in the small intestine of patients with chronic nonspecific enteritis].
Topics: Adult; Alanine; Chronic Disease; Dipeptidases; Dipeptides; Enteritis; Female; Glutamates; Glycine; Humans; Intestine, Small; Isoleucine; Leucine; Male; Middle Aged; Proline; Valine | 1975 |
The postnatal changes in the circulating free amino acid pool in the newborn infant. 3. The plasma amino acid ratio in infants born after pregnancies complicated by toxaemia, placental infarction, impaired umbilical circulation and chronic maternal diseas
Topics: Amino Acids; Chronic Disease; Female; Glutamine; Glycine; Heart Defects, Congenital; Heart Failure; Humans; Infant, Newborn; Infarction; Isoleucine; Leucine; Maternal-Fetal Exchange; Methionine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pyelonephritis; Serine; Taurine; Torsion Abnormality; Umbilical Cord; Valine | 1971 |